DexCom DXCM Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.82B+16.1% | $4.66B+15.6% | $4.52B+14.2% | $4.3B+9.3% | $4.15B+9.1% | ||
| $1.85B+10.2% | $1.86B+16.6% | $1.85B+22.2% | $1.77B+20.9% | $1.68B+19.0% | ||
| $2.96B+20.2% | $2.8B+14.9% | $2.67B+9.3% | $2.53B+2.4% | $2.47B+3.2% | ||
| 61.5%+2.1pp | 60.1%-0.4pp | 59%-2.7pp | 58.8%-4.0pp | 59.4%-3.4pp | ||
| $599.2M+7.8% | $599.1M+8.5% | $590.4M+7.5% | $568.3M+4.3% | $556.1M+5.3% | ||
| $1.33B+4.2% | $1.29B+0.4% | $1.3B+2.8% | $1.27B+2.4% | $1.28B+5.7% | ||
| $258.9M+15.0% | $251.8M+15.7% | $244.4M+15.1% | $236.1M+48.7% | $225.2M+108% | ||
| $1.93B+5.3% | $1.89B+2.8% | $1.89B+4.2% | $1.84B+3.0% | $1.83B+5.5% | ||
| $1.93B+5.3% | $1.89B+2.8% | $1.89B+4.2% | $1.84B+3.0% | $1.83B+5.5% | ||
| $1.03B+63.4% | $911.8M+52.0% | $777.7M+23.8% | $687.2M+0.8% | $632.6M-2.9% | ||
| 21.4%+6.2pp | 19.6%+4.7pp | 17.2%+1.3pp | 16%-1.3pp | 15.3%-1.9pp | ||
| $170.2M+73.3% | $176.6M+62.0% | $181.3M+56.4% | $96.9M-22.7% | $98.2M-22.6% | ||
| $1.2B+64.7% | $1.09B+53.5% | $959M+28.9% | $784.1M-2.8% | $730.8M-6.1% | ||
| $273.2M+39.7% | $252.1M+89.8% | $238.3M+226% | $212.6M+41.6% | $195.6M+31.1% | ||
| $930.4M+73.8% | $836.3M+45.1% | $720.7M+5.9% | $571.5M-14.3% | $535.2M-16.3% | ||
| 19.3%+6.4pp | 17.9%+3.7pp | 16%-1.3pp | 13.3%-3.7pp | 12.9%-3.9pp | ||
| $2.33+73.9% | $2.09+46.2% | $1.80+8.4% | $1.44-10.6% | $1.34-13.0% | ||
| $2.40+77.8% | $2.15+47.3% | $1.84+5.7% | $1.45-15.2% | $1.35-18.2% | ||
| 1.6B-2.0% | 1.6B-1.7% | 1.6B-2.0% | 1.6B-2.8% | 1.6B-3.1% | ||
| 1.6B-1.2% | 1.6B-0.8% | 1.6B-0.1% | 1.6B+0.6% | 1.6B+1.8% | ||
| $170.2M+73.3% | $176.6M+62.0% | $181.3M+56.4% | $96.9M-22.7% | $98.2M-22.6% | ||
| $4.82B+16.1% | $4.66B+15.6% | $4.52B+14.2% | $4.3B+9.3% | $4.15B+9.1% | ||
| $1.29B+50.7% | $1.16B+42.3% | $1.02B+21.6% | $923.3M+4.1% | $857.8M+1.1% | ||
| 26.8%+6.1pp | 25%+4.7pp | 22.6%+1.4pp | 21.5%-1.1pp | 20.7%-1.6pp | ||
| $1.03B+63.4% | $911.8M+52.0% | $777.7M+23.8% | $687.2M+0.8% | $632.6M-2.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is DexCom's revenue?
- DexCom (DXCM) generated $4.8B in revenue over the trailing twelve months, up 16.2% year over year.
- Is DexCom profitable?
- DexCom reported $930.4M in net income over the trailing twelve months, a 19.3% net margin.
- What are DexCom's profit margins?
- Gross margin is 61.5% and operating margin is 21.4%, with a 19.3% net margin.
- What is DexCom's earnings per share?
- DexCom's diluted EPS over the trailing twelve months is $2.33.
- Where does DexCom's income statement data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
